RecruitingNot Applicable

Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

Spain296 participantsStarted 2024-05-01

Plain-language summary

The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time and that required hospital admission. * Informed consent signature. Exclusion Criteria: * Neuromuscular disease * Not having received neuromuscular block during the intervention * Admission to the outpatient surgery unit * Admission to the postoperative intensive care unit * Patients who signed informed consent, but postoperative data could not be collected upon arrival at the PACU.

What they're measuring

Residual Neuromuscular Block

Timeframe: 5 minutes postoperatively

Residual Neuromuscular Block

Timeframe: 8 minutes postoperatively

Trial details

NCT IDNCT06386354

SponsorDr. Negrin University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-30

Contact for this trial

Ángel Becerra Bolaños, PhD

+34928450370 angbecbol@gmail.com